PUBMED FOR HANDHELDS

Journal Abstract Search


235 related items for PubMed ID: 22926607

  • 1. Omega-3 fatty acid treatment, with or without cytidine, fails to show therapeutic properties in bipolar disorder: a double-blind, randomized add-on clinical trial.
    Murphy BL, Stoll AL, Harris PQ, Ravichandran C, Babb SM, Carlezon WA, Cohen BM.
    J Clin Psychopharmacol; 2012 Oct; 32(5):699-703. PubMed ID: 22926607
    [Abstract] [Full Text] [Related]

  • 2. Clinical trial to evaluate omega-3 fatty acids and alternate day prednisone in patients with IgA nephropathy: report from the Southwest Pediatric Nephrology Study Group.
    Hogg RJ, Lee J, Nardelli N, Julian BA, Cattran D, Waldo B, Wyatt R, Jennette JC, Sibley R, Hyland K, Fitzgibbons L, Hirschman G, Donadio JV, Holub BJ, Southwest Pediatric Nephrology Study Group.
    Clin J Am Soc Nephrol; 2006 May; 1(3):467-74. PubMed ID: 17699247
    [Abstract] [Full Text] [Related]

  • 3. A Double-Blind Placebo-Controlled Trial of Omega-3 Fatty Acids as a Monotherapy for Adolescent Depression.
    Gabbay V, Freed RD, Alonso CM, Senger S, Stadterman J, Davison BA, Klein RG.
    J Clin Psychiatry; 2018 Jun 26; 79(4):. PubMed ID: 29985566
    [Abstract] [Full Text] [Related]

  • 4. Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation.
    da Silva TM, Munhoz RP, Alvarez C, Naliwaiko K, Kiss A, Andreatini R, Ferraz AC.
    J Affect Disord; 2008 Dec 26; 111(2-3):351-9. PubMed ID: 18485485
    [Abstract] [Full Text] [Related]

  • 5. Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial.
    Amminger GP, Schäfer MR, Papageorgiou K, Klier CM, Cotton SM, Harrigan SM, Mackinnon A, McGorry PD, Berger GE.
    Arch Gen Psychiatry; 2010 Feb 26; 67(2):146-54. PubMed ID: 20124114
    [Abstract] [Full Text] [Related]

  • 6. Omega-3 for bipolar disorder: meta-analyses of use in mania and bipolar depression.
    Sarris J, Mischoulon D, Schweitzer I.
    J Clin Psychiatry; 2012 Jan 26; 73(1):81-6. PubMed ID: 21903025
    [Abstract] [Full Text] [Related]

  • 7. ω-3 fatty acid treatment in multiple sclerosis (OFAMS Study): a randomized, double-blind, placebo-controlled trial.
    Torkildsen O, Wergeland S, Bakke S, Beiske AG, Bjerve KS, Hovdal H, Midgard R, Lilleås F, Pedersen T, Bjørnarå B, Dalene F, Kleveland G, Schepel J, Olsen IC, Myhr KM.
    Arch Neurol; 2012 Aug 26; 69(8):1044-51. PubMed ID: 22507886
    [Abstract] [Full Text] [Related]

  • 8. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial.
    Freund-Levi Y, Eriksdotter-Jönhagen M, Cederholm T, Basun H, Faxén-Irving G, Garlind A, Vedin I, Vessby B, Wahlund LO, Palmblad J.
    Arch Neurol; 2006 Oct 26; 63(10):1402-8. PubMed ID: 17030655
    [Abstract] [Full Text] [Related]

  • 9. A randomized, placebo-controlled trial of citicoline add-on therapy in outpatients with bipolar disorder and cocaine dependence.
    Brown ES, Gorman AR, Hynan LS.
    J Clin Psychopharmacol; 2007 Oct 26; 27(5):498-502. PubMed ID: 17873684
    [Abstract] [Full Text] [Related]

  • 10. Effectiveness of adjunctive antidepressant treatment for bipolar depression.
    Sachs GS, Nierenberg AA, Calabrese JR, Marangell LB, Wisniewski SR, Gyulai L, Friedman ES, Bowden CL, Fossey MD, Ostacher MJ, Ketter TA, Patel J, Hauser P, Rapport D, Martinez JM, Allen MH, Miklowitz DJ, Otto MW, Dennehy EB, Thase ME.
    N Engl J Med; 2007 Apr 26; 356(17):1711-22. PubMed ID: 17392295
    [Abstract] [Full Text] [Related]

  • 11. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.
    McIntyre RS, Konarski JZ, Jones M, Paulsson B.
    J Affect Disord; 2007 Apr 26; 100 Suppl 1():S5-14. PubMed ID: 17391773
    [Abstract] [Full Text] [Related]

  • 12. Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial.
    Cutler AJ, Datto C, Nordenhem A, Minkwitz M, Acevedo L, Darko D.
    Clin Ther; 2011 Nov 26; 33(11):1643-58. PubMed ID: 22054797
    [Abstract] [Full Text] [Related]

  • 13. Quetiapine monotherapy for mania associated with bipolar disorder: combined analysis of two international, double-blind, randomised, placebo-controlled studies.
    Vieta E, Mullen J, Brecher M, Paulsson B, Jones M.
    Curr Med Res Opin; 2005 Jun 26; 21(6):923-34. PubMed ID: 15969892
    [Abstract] [Full Text] [Related]

  • 14. A double-blind, placebo-controlled trial of ω-3 fatty acids in Tourette's disorder.
    Gabbay V, Babb JS, Klein RG, Panzer AM, Katz Y, Alonso CM, Petkova E, Wang J, Coffey BJ.
    Pediatrics; 2012 Jun 26; 129(6):e1493-500. PubMed ID: 22585765
    [Abstract] [Full Text] [Related]

  • 15. Omega-3 fatty acids in bipolar disorder: clinical and research considerations.
    Marangell LB, Suppes T, Ketter TA, Dennehy EB, Zboyan H, Kertz B, Nierenberg A, Calabrese J, Wisniewski SR, Sachs G.
    Prostaglandins Leukot Essent Fatty Acids; 2006 Jun 26; 75(4-5):315-21. PubMed ID: 16928441
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study).
    Thase ME, Macfadden W, Weisler RH, Chang W, Paulsson B, Khan A, Calabrese JR, BOLDER II Study Group.
    J Clin Psychopharmacol; 2006 Dec 26; 26(6):600-9. PubMed ID: 17110817
    [Abstract] [Full Text] [Related]

  • 17. Omega-3 fatty acids as a treatment for perinatal depression: randomized double-blind placebo-controlled trial.
    Rees AM, Austin MP, Parker GB.
    Aust N Z J Psychiatry; 2008 Mar 26; 42(3):199-205. PubMed ID: 18247194
    [Abstract] [Full Text] [Related]

  • 18. A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder.
    DelBello MP, Chang K, Welge JA, Adler CM, Rana M, Howe M, Bryan H, Vogel D, Sampang S, Delgado SV, Sorter M, Strakowski SM.
    Bipolar Disord; 2009 Aug 26; 11(5):483-93. PubMed ID: 19624387
    [Abstract] [Full Text] [Related]

  • 19. Protein kinase C inhibition in the treatment of mania: a double-blind, placebo-controlled trial of tamoxifen.
    Yildiz A, Guleryuz S, Ankerst DP, Ongür D, Renshaw PF.
    Arch Gen Psychiatry; 2008 Mar 26; 65(3):255-63. PubMed ID: 18316672
    [Abstract] [Full Text] [Related]

  • 20. Allopurinol as an adjunct to lithium and haloperidol for treatment of patients with acute mania: a double-blind, randomized, placebo-controlled trial.
    Akhondzadeh S, Milajerdi MR, Amini H, Tehrani-Doost M.
    Bipolar Disord; 2006 Oct 26; 8(5 Pt 1):485-9. PubMed ID: 17042886
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.